Neuromodulation Program News Today

Transcranial magnetic stimulation (TMS) is a noninvasive in-office procedure. Brief magnetic pulses to the brain induces electrical currents that stimulate nerve cells in specific areas of the brain, providing symptom relief for patients with depression and OCD.

Using an old anesthesia drug to pull people out of severe depression has gone from fringe idea to widespread use in just a few years.

<p style="text-align:start">Ketamine has received a lot of attention as a potential treatment for depression, but few studies have revealed how well it works in real world settings, especially in patients with complex mental health needs. Now, a new study of data from veterans who had tried many depression treatments but still had severe symptoms suggests <a href="https://www.psychiatrist.com/jcp/clinical-outcomes-intravenous-ketamine-for-depression-va-h...

A new study of data from veterans who had tried many depression treatments but still had severe symptoms suggests a series of intravenous doses of ketamine gave

A new study of data from veterans who had tried many depression treatments but still had severe symptoms suggests a series of intravenous doses of ketamine gave

Beckers honors 36 hospitals and health systems with great psychiatry, mental health and behavioral health programs that address this vital gap in healthcare.

By targeting the precuneus in patients with Alzheimers disease, investigators using rTMS are hoping to stimulate or repair neural connections in the default mode network.

Sinaptica Therapeutics Announces Publication of Positive Results from Phase II Trial Evaluating the Potential of Precision-Delivered Noninvasive Neurostimulation Treatment for Mild-to-Moderate Alzheimer’s Disease - read this article along with other careers information, tips and advice on BioSpace